| - GRCh37:
- Chr9:21974667-22160087
| CDKN2A, CDKN2B, CDKN2B-AS1 | | Familial melanoma | Uncertain significance (Sep 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971106-21972068
| CDKN2A | | Familial melanoma | Pathogenic (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21968228-21971217
| CDKN2A | | Familial melanoma | Pathogenic (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970891-21973573
| CDKN2A | | Familial melanoma | Pathogenic (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:57534470-58190366
| AGAP2, ARHGAP9, ARHGEF25, B4GALNT1, CDK4, CYP27B1, DCTN2, DDIT3, DTX3, EEF1AKMT3, GLI1, INHBC, INHBE, KIF5A, LRP1, MARCHF9, MARS1, MBD6, METTL1, MIR616, NDUFA4L2, NXPH4, OS9, PIP4K2C, R3HDM2, SHMT2, STAC3, TSFM, TSPAN31 | | Familial melanoma | Uncertain significance (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144696-58145500
| CDK4 | | Familial melanoma | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144419-58160824
| MARCHF9, CDK4, CYP27B1 | | Familial melanoma | Uncertain significance (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142308-58145500
| CDK4 | | Familial melanoma | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144780
- GRCh38:
- Chr12:57750997
| CDK4 | S150G | Familial melanoma | Uncertain significance (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971185
- GRCh38:
- Chr9:21971186
| CDKN2A | R58L, R7L | Familial melanoma | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971108
- GRCh38:
- Chr9:21971109
| CDKN2A | D84H, R98P, D33H | Familial melanoma | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142408
- GRCh38:
- Chr12:57748625
| MIR6759, CDK4, TSPAN31 | | Familial melanoma | Likely benign (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144838
- GRCh38:
- Chr12:57751055
| CDK4 | | Familial melanoma | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145453
- GRCh38:
- Chr12:57751670
| CDK4 | | Familial melanoma | Likely benign (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144691
- GRCh38:
- Chr12:57750908
| CDK4 | | Familial melanoma | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144723
- GRCh38:
- Chr12:57750940
| CDK4 | I29T, M169V | Familial melanoma | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974809
- GRCh38:
- Chr9:21974810
| CDKN2A | | Familial melanoma, Hereditary cancer-predisposing syndrome | Likely benign (Jun 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:58143307
- GRCh38:
- Chr12:57749524
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Sep 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144515
- GRCh38:
- Chr12:57750732
| CDK4 | R12K, L186F | Familial melanoma | Uncertain significance (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142957
- GRCh38:
- Chr12:57749174
| CDK4, TSPAN31 | | Familial melanoma | Uncertain significance (Jan 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970942
- GRCh38:
- Chr9:21970943
| CDKN2A | G88V, G139V | Familial melanoma | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144426
- GRCh38:
- Chr12:57750643
| CDK4 | | Familial melanoma | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145268
- GRCh38:
- Chr12:57751485
| CDK4, LOC130008148 | | Familial melanoma | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974662
- GRCh38:
- Chr9:21974663
| CDKN2A | | Familial melanoma | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143055
- GRCh38:
- Chr12:57749272
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143052
- GRCh38:
- Chr12:57749269
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144972
- GRCh38:
- Chr12:57751189
| CDK4 | | Familial melanoma | Likely benign (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142998
- GRCh38:
- Chr12:57749215
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145136
- GRCh38:
- Chr12:57751353
| CDK4 | | Familial melanoma | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143112
- GRCh38:
- Chr12:57749329
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143036
- GRCh38:
- Chr12:57749253
| CDK4, TSPAN31 | P250A | Familial melanoma | Uncertain significance (Sep 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971065
- GRCh38:
- Chr9:21971066
| CDKN2A | H98R, H47R | Familial melanoma | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142952
- GRCh38:
- Chr12:57749169
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970971
- GRCh38:
- Chr9:21970972
| CDKN2A | Y78*, Y129* | Familial melanoma | Pathogenic (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144976
- GRCh38:
- Chr12:57751193
| CDK4 | | Familial melanoma | Likely benign (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143298
- GRCh38:
- Chr12:57749515
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974711
- GRCh38:
- Chr9:21974712
| CDKN2A | N39S | Familial melanoma | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971194
- GRCh38:
- Chr9:21971195
| CDKN2A | G4V, G55V | Familial melanoma | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971107
- GRCh38:
- Chr9:21971108
| CDKN2A | D84V, D33V | Familial melanoma | Likely pathogenic (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142317-58142331
- GRCh38:
- Chr12:57748534-57748548
| TSPAN31, CDK4 | | Familial melanoma | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145419
- GRCh38:
- Chr12:57751636
| CDK4 | S28G | Familial melanoma | Uncertain significance (May 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971202
- GRCh38:
- Chr9:21971203
| CDKN2A | D67H, M1I, M52I | Hereditary cancer-predisposing syndrome, Familial melanoma | Uncertain significance (Feb 28, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:58144505
- GRCh38:
- Chr12:57750722
| CDK4 | S189Y, D9Y | Familial melanoma | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974812
- GRCh38:
- Chr9:21974813
| CDKN2A | | Familial melanoma | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143004
- GRCh38:
- Chr12:57749221
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Jul 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145015
- GRCh38:
- Chr12:57751232
| CDK4 | P110R | Familial melanoma | Uncertain significance (Jul 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974741
- GRCh38:
- Chr9:21974742
| CDKN2A | R29Q | Familial melanoma | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971226
- GRCh38:
- Chr9:21971227
| CDKN2A | | Familial melanoma | Likely benign (Nov 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971183
- GRCh38:
- Chr9:21971184
| CDKN2A | V59L, S73I, V8L | Familial melanoma | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142413
- GRCh38:
- Chr12:57748630
| TSPAN31, CDK4, MIR6759 | | Familial melanoma | Likely benign (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143219
- GRCh38:
- Chr12:57749436
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144745
- GRCh38:
- Chr12:57750962
| CDK4 | | Familial melanoma | Likely benign (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142406-58142407
- GRCh38:
- Chr12:57748623-57748624
| TSPAN31, CDK4, MIR6759 | | Familial melanoma | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145347
- GRCh38:
- Chr12:57751564
| CDK4, LOC130008148 | S52G | Familial melanoma | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145341
- GRCh38:
- Chr12:57751558
| CDK4, LOC130008148 | V54L | Familial melanoma | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143293
- GRCh38:
- Chr12:57749510
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971030
- GRCh38:
- Chr9:21971031
| CDKN2A | L124P, W110R, W59R | Familial melanoma | Uncertain significance (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142383
- GRCh38:
- Chr12:57748600
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142997
- GRCh38:
- Chr12:57749214
| TSPAN31, CDK4 | E263K | Familial melanoma | Uncertain significance (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144728
- GRCh38:
- Chr12:57750945
| CDK4 | Y167C | Hereditary cancer-predisposing syndrome, Familial melanoma | Uncertain significance (May 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:21971072
- GRCh38:
- Chr9:21971073
| CDKN2A | G110V, V96L, V45L | Familial melanoma | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143105
- GRCh38:
- Chr12:57749322
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144541
- GRCh38:
- Chr12:57750758
| CDK4 | T177I, V21I | Familial melanoma | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144527
- GRCh38:
- Chr12:57750744
| CDK4 | A16D, A182S | Familial melanoma | Uncertain significance (Nov 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971090
- GRCh38:
- Chr9:21971091
| CDKN2A | F90L, L104P, F39L | Familial melanoma | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970910
- GRCh38:
- Chr9:21970911
| CDKN2A | G99C, G150C | Hereditary cancer-predisposing syndrome, Familial melanoma | Uncertain significance (Jul 3, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:58143267
- GRCh38:
- Chr12:57749484
| TSPAN31, CDK4 | S218F | Familial melanoma | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144822
- GRCh38:
- Chr12:57751039
| CDK4 | I136V | Familial melanoma | Uncertain significance (Jan 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971093
- GRCh38:
- Chr9:21971094
| CDKN2A | G38C, G89C, G103V | Familial melanoma | Uncertain significance (Jan 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144993
- GRCh38:
- Chr12:57751210
| CDK4 | | Familial melanoma | Likely benign (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21968229
- GRCh38:
- Chr9:21968230
| CDKN2A | | Familial melanoma | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971185
- GRCh38:
- Chr9:21971186
| CDKN2A | R7Q, R58Q | Familial melanoma | Uncertain significance (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145352
- GRCh38:
- Chr12:57751569
| CDK4, LOC130008148 | P50L | Familial melanoma | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142340
- GRCh38:
- Chr12:57748557
| CDK4, TSPAN31 | Y294H | Familial melanoma | Uncertain significance (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21968246
- GRCh38:
- Chr9:21968247
| CDKN2A | | Familial melanoma | Likely benign (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143111
- GRCh38:
- Chr12:57749328
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145046
- GRCh38:
- Chr12:57751263
| CDK4 | | Familial melanoma | Likely benign (Dec 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971054-21971055
- GRCh38:
- Chr9:21971055-21971056
| CDKN2A | A51fs, A102fs, G116fs | Familial melanoma | Pathogenic (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145286
- GRCh38:
- Chr12:57751503
| CDK4, LOC130008148 | V72A | Familial melanoma | Uncertain significance (Dec 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971132
- GRCh38:
- Chr9:21971133
| CDKN2A | A76S, A25S, R90L | Familial melanoma | Uncertain significance (Feb 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143083
- GRCh38:
- Chr12:57749300
| CDK4, TSPAN31 | P234Q | Familial melanoma | Uncertain significance (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145061
- GRCh38:
- Chr12:57751278
| CDK4 | H95Y | Familial melanoma | Uncertain significance (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143106
- GRCh38:
- Chr12:57749323
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21968244
- GRCh38:
- Chr9:21968245
| CDKN2A | | Familial melanoma | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58145300
- GRCh38:
- Chr12:57751517
| CDK4, LOC130008148 | | Familial melanoma | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143225
- GRCh38:
- Chr12:57749442
| TSPAN31, CDK4 | | Familial melanoma | Likely benign (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144521
- GRCh38:
- Chr12:57750738
| CDK4 | E184*, S14* | Familial melanoma | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971084
- GRCh38:
- Chr9:21971085
| CDKN2A | D41H, D92H, G106A | Familial melanoma | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970978
- GRCh38:
- Chr9:21970979
| CDKN2A | A127V, A76V | Familial melanoma | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142365
- GRCh38:
- Chr12:57748582
| CDK4, TSPAN31 | | Familial melanoma | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974741
- GRCh38:
- Chr9:21974742
| CDKN2A | R29L | Familial melanoma | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144973
- GRCh38:
- Chr12:57751190
| CDK4 | | Familial melanoma | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970926
- GRCh38:
- Chr9:21970927
| CDKN2A | | Familial melanoma | Likely benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58142414
- GRCh38:
- Chr12:57748631
| CDK4, MIR6759, TSPAN31 | | Familial melanoma | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21971015
- GRCh38:
- Chr9:21971016
| CDKN2A | R129P, V64L, V115L | Familial melanoma | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144798
- GRCh38:
- Chr12:57751015
| CDK4 | E144K | Familial melanoma | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21970920
- GRCh38:
- Chr9:21970921
| CDKN2A | D146E, D95E | Familial melanoma | Uncertain significance (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58144713
- GRCh38:
- Chr12:57750930
| CDK4 | T172R, V26L | Familial melanoma | Uncertain significance (Jun 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:21974729
- GRCh38:
- Chr9:21974730
| CDKN2A | E33G | Familial melanoma | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:58143278
- GRCh38:
- Chr12:57749495
| CDK4, TSPAN31 | F214L | Familial melanoma | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |